AU2001248751A1 - Compositions disintegrating in oral cavity and preparations disintegrating in oral cavity - Google Patents
Compositions disintegrating in oral cavity and preparations disintegrating in oral cavityInfo
- Publication number
- AU2001248751A1 AU2001248751A1 AU2001248751A AU4875101A AU2001248751A1 AU 2001248751 A1 AU2001248751 A1 AU 2001248751A1 AU 2001248751 A AU2001248751 A AU 2001248751A AU 4875101 A AU4875101 A AU 4875101A AU 2001248751 A1 AU2001248751 A1 AU 2001248751A1
- Authority
- AU
- Australia
- Prior art keywords
- disintegrating
- oral cavity
- preparations
- compositions
- oral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Neurosurgery (AREA)
- Nutrition Science (AREA)
- Endocrinology (AREA)
- Neurology (AREA)
- Obesity (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Physiology (AREA)
- Epidemiology (AREA)
- Reproductive Health (AREA)
- Zoology (AREA)
- Urology & Nephrology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000-110396 | 2000-04-12 | ||
JP2000110396 | 2000-04-12 | ||
PCT/JP2001/003114 WO2001076565A1 (fr) | 2000-04-12 | 2001-04-11 | Compositions et preparations se desintegrant dans la cavite buccale |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001248751A1 true AU2001248751A1 (en) | 2001-10-23 |
Family
ID=18622916
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001248751A Abandoned AU2001248751A1 (en) | 2000-04-12 | 2001-04-11 | Compositions disintegrating in oral cavity and preparations disintegrating in oral cavity |
Country Status (3)
Country | Link |
---|---|
JP (2) | JP4802436B2 (ja) |
AU (1) | AU2001248751A1 (ja) |
WO (1) | WO2001076565A1 (ja) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001076565A1 (fr) * | 2000-04-12 | 2001-10-18 | Banyu Pharmaceutical Co., Ltd. | Compositions et preparations se desintegrant dans la cavite buccale |
JP5584509B2 (ja) * | 2003-02-28 | 2014-09-03 | 東和薬品株式会社 | 口腔内崩壊錠剤 |
JP4551627B2 (ja) * | 2003-02-28 | 2010-09-29 | 東和薬品株式会社 | 口腔内崩壊錠剤の製造方法 |
JP5062871B2 (ja) * | 2003-05-13 | 2012-10-31 | 東和薬品株式会社 | 苦味を低減した口腔内崩壊錠剤 |
JP5062872B2 (ja) * | 2003-08-13 | 2012-10-31 | 東和薬品株式会社 | 不快な味を低減した口腔内崩壊錠剤 |
JP2005306770A (ja) * | 2004-04-21 | 2005-11-04 | Toa Eiyo Ltd | 口腔内速崩壊型製剤及びその製造方法 |
EP1886678B1 (en) | 2005-05-18 | 2017-04-19 | Sumitomo Dainippon Pharma Co., Ltd. | Stable tablet containing droxidopa |
US8778392B2 (en) * | 2007-03-13 | 2014-07-15 | Dainippon Sumitomo Pharma Co., Ltd. | Oral disintegrating tablet |
CN101686976B (zh) | 2007-04-26 | 2013-04-24 | 东丽株式会社 | 含有4,5-环氧基吗啡喃衍生物的稳定的固体制剂 |
US9314454B2 (en) | 2007-12-28 | 2016-04-19 | Sawai Pharmaceutical Co., Ltd. | Oral cavity disintegrating tablet and method of producing the same |
JP2011513194A (ja) * | 2008-02-29 | 2011-04-28 | 大塚製薬株式会社 | 口腔内崩壊錠 |
KR101618388B1 (ko) * | 2008-06-13 | 2016-05-04 | 다이닛본 스미토모 세이야꾸 가부시끼가이샤 | 구강 내 급속 붕해 정제 및 이의 제조 방법 |
EP2397161B1 (en) * | 2009-02-12 | 2019-09-25 | Fuji Chemical Industry Co., Ltd. | Disintegrating particle composition and rapidly disintegrating compression-molded material comprising same |
JP5534004B2 (ja) * | 2010-03-29 | 2014-06-25 | アステラス製薬株式会社 | 口腔内崩壊錠 |
JP5614445B2 (ja) * | 2010-03-29 | 2014-10-29 | アステラス製薬株式会社 | 経口投与用粒子状医薬組成物 |
US8426461B2 (en) | 2011-01-17 | 2013-04-23 | Takeda Pharmaceutical Company Limited | Orally dispersible tablet |
AR084865A1 (es) | 2011-01-17 | 2013-07-10 | Takeda Pharmaceutical | Preparacion de desintegracion rapida, comprimido dispersable por via oral |
KR102145641B1 (ko) | 2012-06-05 | 2020-08-18 | 다케다 야쿠힌 고교 가부시키가이샤 | 고형 제제 |
JP5713421B1 (ja) | 2013-07-19 | 2015-05-07 | 株式会社三和化学研究所 | 口腔内崩壊錠 |
GB201400034D0 (en) * | 2014-01-02 | 2014-02-19 | Astrazeneca Ab | Pharmaceutical Compositions comprising AZD9291 |
WO2017064815A1 (ja) * | 2015-10-16 | 2017-04-20 | 持田製薬株式会社 | 低用量薬物を含有する口腔内崩壊錠 |
CN108472256A (zh) * | 2015-12-28 | 2018-08-31 | 日本新药株式会社 | 压缩成型制剂 |
JP6858575B2 (ja) * | 2016-01-29 | 2021-04-14 | 沢井製薬株式会社 | ナルフラフィン含有口腔内崩壊錠 |
JP7138666B2 (ja) * | 2018-01-24 | 2022-09-16 | 大原薬品工業株式会社 | γ-アミノ酪酸誘導体含有錠剤の化学的安定性を改善する方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2523384B2 (ja) * | 1990-02-02 | 1996-08-07 | エスエス製薬株式会社 | 発泡性製剤組成物 |
JP2919771B2 (ja) * | 1995-04-17 | 1999-07-19 | 佐藤製薬株式会社 | 速溶解性錠剤の製造方法及び該製造方法により製造した速溶解性錠剤 |
JPH09194381A (ja) * | 1996-01-17 | 1997-07-29 | Kowa Co | カルシウム塩含有チュアブル錠 |
DK0922464T3 (da) * | 1996-07-12 | 2005-06-06 | Daiichi Seiyaku Co | Hurtigt desintegrerbare, kompressionsstöbte materialer og fremgangsmåder til fremstilling af samme |
JPH10182436A (ja) * | 1996-10-31 | 1998-07-07 | Takeda Chem Ind Ltd | 固形医薬製剤 |
JPH10287555A (ja) * | 1997-04-14 | 1998-10-27 | Kowa Co | チュアブル錠 |
JPH10298062A (ja) * | 1997-04-24 | 1998-11-10 | Pfizer Pharmaceut Co Ltd | 口腔内速溶型錠剤 |
CA2581111A1 (en) * | 1998-07-28 | 2000-02-10 | Takeda Pharmaceutical Company Limited | Rapidly disintegrable solid preparation |
JP4504467B2 (ja) * | 1998-07-30 | 2010-07-14 | 佐藤製薬株式会社 | 口腔内崩壊性錠剤 |
JP2000178182A (ja) * | 1998-12-17 | 2000-06-27 | Lion Corp | 崩壊性組成物 |
WO2001076565A1 (fr) * | 2000-04-12 | 2001-10-18 | Banyu Pharmaceutical Co., Ltd. | Compositions et preparations se desintegrant dans la cavite buccale |
-
2001
- 2001-04-11 WO PCT/JP2001/003114 patent/WO2001076565A1/ja active Application Filing
- 2001-04-11 AU AU2001248751A patent/AU2001248751A1/en not_active Abandoned
- 2001-04-11 JP JP2001574083A patent/JP4802436B2/ja not_active Expired - Fee Related
-
2011
- 2011-06-16 JP JP2011134262A patent/JP2011225588A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2011225588A (ja) | 2011-11-10 |
JPWO2001076565A1 (ja) | 2004-06-10 |
WO2001076565A1 (fr) | 2001-10-18 |
JP4802436B2 (ja) | 2011-10-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001248751A1 (en) | Compositions disintegrating in oral cavity and preparations disintegrating in oral cavity | |
AU2001268743A1 (en) | Oral care compositions comprising chlorite and methods | |
AU2002230217A1 (en) | Tablets quickly disintegrated in oral cavity | |
AU2001283749A1 (en) | Tools and methods for creating cavities in bone | |
AU2001294250A1 (en) | Medicinal compositions quickly disintegrating in the oral cavity and process forproducing the same | |
AU2778801A (en) | Antisense compositions and methods | |
AU2001294814A1 (en) | Pumpcn compositions and uses thereof | |
AU7645701A (en) | Cosmetic or pharmaceutical composition in solid form comprising bis-acyl-amides | |
AU6049401A (en) | Improvements in or relating to perfumes | |
AU2001233739A1 (en) | Use of natural substances in the production of cosmetic preparations | |
AU2001238363A1 (en) | Compositions for preventing cellulite in mammalian skin | |
AU4967601A (en) | Stable and efficacious soft solid product | |
AU2002358594A1 (en) | Emollients and cosmetic compositions | |
AU7924200A (en) | Tooth whitening products and procedures | |
AU2001261375A1 (en) | Human caspase-12 materials and methods | |
AU2002306461A1 (en) | In vivo delivery methods and compositions | |
AU2738000A (en) | Oral hygiene preparations; associated methods and kit | |
AU2002211690A1 (en) | Altered hox and wnt7a expression in human lung cancer | |
AU2001261317A1 (en) | Immunostimulant compositions and associated methods | |
AU4876701A (en) | Peptide derivatives and medicinal compositions | |
AU2001241187A1 (en) | Sustained release oral preparations | |
AU2001258714A1 (en) | Herbal composition useful for treatment or oral cavity and method for its local delivery thereof | |
AU2001290072A1 (en) | Improvements in and relating to shuttering | |
AU2002226986A1 (en) | In vivo delivery methods and compositions | |
AU2001259564A1 (en) | Pharmaceutical compositions and methods for use |